__timestamp | Alpine Immune Sciences, Inc. | Jazz Pharmaceuticals plc |
---|---|---|
Wednesday, January 1, 2014 | 2287709 | 406114000 |
Thursday, January 1, 2015 | 6844000 | 449119000 |
Friday, January 1, 2016 | 8586000 | 502892000 |
Sunday, January 1, 2017 | 6079000 | 544156000 |
Monday, January 1, 2018 | 8362000 | 683530000 |
Tuesday, January 1, 2019 | 9467000 | 736942000 |
Wednesday, January 1, 2020 | 10899000 | 854233000 |
Friday, January 1, 2021 | 14560000 | 1451683000 |
Saturday, January 1, 2022 | 17968000 | 1416967000 |
Sunday, January 1, 2023 | 22222000 | 1343105000 |
Unleashing insights
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. Jazz Pharmaceuticals and Alpine Immune Sciences, two prominent companies, have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Jazz Pharmaceuticals consistently reported higher SG&A expenses, peaking at approximately $1.45 billion in 2021. This represents a staggering 3,500% increase compared to Alpine Immune Sciences' highest expense of around $22 million in 2023. Alpine, while smaller in scale, has shown a steady growth in its SG&A expenses, nearly doubling from 2014 to 2023. This data not only highlights the scale of operations but also reflects strategic investments in marketing and administration. As the industry evolves, these financial insights provide a window into the operational priorities of these pharmaceutical giants.
Johnson & Johnson and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Merck & Co., Inc. or Alpine Immune Sciences, Inc.: Who Manages SG&A Costs Better?
Amgen Inc. and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Jazz Pharmaceuticals plc
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Walgreens Boots Alliance, Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Jazz Pharmaceuticals plc or CymaBay Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Vericel Corporation Trends and Insights
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Evotec SE